Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F B Wright

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Circulation|November 26, 2014
Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis"Paul K L Chin, Daniel F B Wright, Christopher M Florkowski
Trials|April 16, 2026
Guideline for the Measurement, Analysis and Reporting of Medication Adherence during the Run-in phase of clinical trials (MARMAR)Non Davies, Bernard Vrijens, Daniel F B Wright, et al.
British Journal of Clinical Pharmacology|December 20, 2020
The propagation of between-subject variability from dose to responseHesham S Al-Sallami, Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology|April 27, 2013
Is the dose of dabigatran really more predictable than warfarin?Daniel F B Wright, Hesham S Al-Sallami, Stephen B Duffull
British Journal of Clinical Pharmacology|July 27, 2025
Medication adherence during the run-in phase of clinical trials: A systematic review of methodological and reporting rigourNon Davies, Bernard Vrijens, Daniel F B Wright, et al.
Research in Social & Administrative Pharmacy : RSAP|February 21, 2025
Foundational concepts in Cultural-Historical Activity Theory: A missing opportunity to address challenges in pharmacy practiceIvana Guarrasi, Nick Hopwood, Andy Blunden, et al.
British Journal of Clinical Pharmacology|November 16, 2019
Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation mattersQing Xi Ooi, Chihiro Hasegawa, Stephen B Duffull, et al.
European Journal of Clinical Pharmacology|October 10, 2018
The intact nephron hypothesis as a model for renal drug handlingSudeep Pradhan, Stephen B Duffull, Robert J Walker, et al.
British Journal of Clinical Pharmacology|October 4, 2018
Response to 'Comment on ''Massive' metformin overdose' by Chiew et al.'Angela L Chiew, Daniel F B Wright, Michael S Roberts, et al.
The AAPS Journal|August 7, 2019
Evaluation of Assumptions Underpinning Pharmacometric ModelsQing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Circulation|November 26, 2014
Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis"Paul K L Chin, Daniel F B Wright, Christopher M Florkowski
Trials|April 16, 2026
Guideline for the Measurement, Analysis and Reporting of Medication Adherence during the Run-in phase of clinical trials (MARMAR)Non Davies, Bernard Vrijens, Daniel F B Wright, et al.
British Journal of Clinical Pharmacology|December 20, 2020
The propagation of between-subject variability from dose to responseHesham S Al-Sallami, Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology|April 27, 2013
Is the dose of dabigatran really more predictable than warfarin?Daniel F B Wright, Hesham S Al-Sallami, Stephen B Duffull
British Journal of Clinical Pharmacology|July 27, 2025
Medication adherence during the run-in phase of clinical trials: A systematic review of methodological and reporting rigourNon Davies, Bernard Vrijens, Daniel F B Wright, et al.
Research in Social & Administrative Pharmacy : RSAP|February 21, 2025
Foundational concepts in Cultural-Historical Activity Theory: A missing opportunity to address challenges in pharmacy practiceIvana Guarrasi, Nick Hopwood, Andy Blunden, et al.
British Journal of Clinical Pharmacology|November 16, 2019
Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation mattersQing Xi Ooi, Chihiro Hasegawa, Stephen B Duffull, et al.
European Journal of Clinical Pharmacology|October 10, 2018
The intact nephron hypothesis as a model for renal drug handlingSudeep Pradhan, Stephen B Duffull, Robert J Walker, et al.
British Journal of Clinical Pharmacology|October 4, 2018
Response to 'Comment on ''Massive' metformin overdose' by Chiew et al.'Angela L Chiew, Daniel F B Wright, Michael S Roberts, et al.
The AAPS Journal|August 7, 2019
Evaluation of Assumptions Underpinning Pharmacometric ModelsQing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
Pageof 8